Vimarsana
Biggest News Aggregation in the World

Page 4 - Aldx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aldx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aldx Today - Breaking & Trending Today

ROSEN, A LEADING NATIONAL FIRM, Encourages Aldeyra - Vimarsana News

ROSEN, A LEADING NATIONAL FIRM, Encourages Aldeyra

NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra...

Aldeyra Therapeutics (NASDAQ:ALDX) Upgraded at StockNews.com - Vimarsana News

Aldeyra Therapeutics (NASDAQ:ALDX) Upgraded at StockNews.com

StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday. Other equities research analysts also recently issued reports about the stock. HC Wainwright reiterated a buy rating and set a $15.00 price objective on shares of Aldeyra Therapeutics […]

Aldeyra Therapeutics (NASDAQ:ALDX) Rating Increased to Hold at StockNews.com - Vimarsana News

Aldeyra Therapeutics (NASDAQ:ALDX) Rating Increased to Hold at StockNews.com

Aldeyra Therapeutics (NASDAQ:ALDX – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a report released on Saturday. ALDX has been the subject of a number of other reports. HC Wainwright reissued a “buy” rating and issued a $15.00 price target on shares of Aldeyra […]

Prosight Management LP Sells 475,262 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Vimarsana News

Prosight Management LP Sells 475,262 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX)

Prosight Management LP decreased its holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) by 55.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 383,447 shares of the biotechnology company’s stock after selling 475,262 shares during the quarter. Aldeyra Therapeutics makes up about […]

Aldeyra Therapeutics (NASDAQ:ALDX) Rating Lowered to Sell at StockNews.com - Vimarsana News

Aldeyra Therapeutics (NASDAQ:ALDX) Rating Lowered to Sell at StockNews.com

StockNews.com lowered shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a report published on Friday morning. A number of other equities analysts have also recently weighed in on ALDX. Oppenheimer reaffirmed an outperform rating and set a $14.00 price target on shares of Aldeyra Therapeutics in […]